A new COVID wave might be coming. Somehow we're not prepared.
Pandemic lulls aren't meant to last. There are new signs that the United States might — emphasis on might — be about to undergo another spike in COVID-19 cases. The CDC this week confirmed that wastewater sampling is showing increased amounts of virus in cities across the country, and a new Omicron subvariant is fueling a fresh wave of illness in Europe. Maybe we'll see a rise in hospitalizations and deaths again, maybe we won't, and it's pointless to panic. But this doesn't seem like a good moment to let our guard down too much.
Somehow, we're not prepared.
The White House and Congress are stuck in gridlock, haggling over a new COVID relief bill that would provide $15 billion in fresh funding for testing, stocks of antiviral drugs for those who need them, and free vaccines for those who want them. Without that money, officials warn those supplies and services will dry up very quickly.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Time is not on our side," an administration official told ABC News. "We need the funding immediately."
So what's the holdup? Arguments over how to pay for the bill, and how long. The details of that debate are less interesting — and less important — than the clear need to be ready if and when the pandemic gets vicious again. Why can't the United States get this right, at long last? We've had enough practice by now, haven't we?
Maybe our attention is diverted: There's a war in Ukraine, after all, that has understandably sucked all the conversational oxygen out of the room. Maybe we've been comforted by the plunging hospitalizations and death rates following the quick-and-dirty Omicron wave. Or maybe we've simply decided that the virus is endemic, no longer worthy of emergency panic after two slogging years.
These are bad excuses. The virus isn't going away because of Russia's invasion — if anything, the war might serve as a breeding ground for COVID and other viruses. Coronavirus deaths are down, but they're still pretty high: 1,268 Americans died of the disease on Wednesday. (For comparison, the CDC says roughly 1,500 people have died of the flu this entire flu season.) And even if the virus has become endemic, that's no reason for federal government inaction. "An endemic threat isn't one that can be ignored but one that must be managed," The Atlantic's Ed Yong wrote Thursday.
The story of the coronavirus pandemic is one of American leaders getting caught with their pants down over and over again. The government wasn't ready for the original virus, prematurely celebrated right before the Delta variant struck, and was still slow to ramp up testing availability ahead of the Omicron spike that started late last year. It's a bipartisan problem. And it leaves us staring down the possibility of another COVID wave without our best defenses firmly in place.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joel Mathis is a writer with 30 years of newspaper and online journalism experience. His work also regularly appears in National Geographic and The Kansas City Star. His awards include best online commentary at the Online News Association and (twice) at the City and Regional Magazine Association.
-
Cautious optimism surrounds plans for the world's first nuclear fusion power plant
Talking Point Some in the industry feel that the plant will face many challenges
By Justin Klawans, The Week US Published
-
2024: the year of Black country artists
In the Spotlight Beyoncé debuted 'Cowboy Carter' at the top of the country charts, shining a spotlight on artists like Shaboozey
By Theara Coleman, The Week US Published
-
Explore new worlds this winter at these 6 enlightening museum exhibitions
The Week Recommends Discover the estrados of Spain and the connection between art and chess in various African countries
By Catherine Garcia, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published